Role of <i>STK11</i> in <i>ALK</i>‑positive non‑small cell lung cancer (Review)-Reference-Cited by-同舟云学术

Role of STK11 in ALK‑positive non‑small cell lung cancer (Review)

Published:2022-04-15 Issue:6 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhou Wen¹,Yan Lu-Da¹,Yu Zhi-Qiong¹,Li Na¹,Yang Yong-Hua¹,Wang Meng¹,Chen Yuan-Yuan¹,Mao Meng-Xia¹,Peng Xiao-Chun²,Cai Jun¹

Affiliation:

1. Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou, Hubei 434023, P.R. China

2. Laboratory of Oncology, Center for Molecular Medicine, School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, Hubei 434023, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference134 articles.

1. Understanding and targeting resistance mechanisms in NSCLC;Rotow;Nat Rev Cancer,2017

2. Breakthrough in targeted therapy for non-small cell lung cancer;Ye;Biomed Pharmacother,2021

3. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008

4. Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review);Yang;Oncol Rep,2021

5. Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC);Brueckl;BMC Cancer,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions;Biomedicines;2024-01-27

2. Will AMPK be a potential therapeutic target for hepatocellular carcinoma?;American Journal of Cancer Research;2024

3. Case Report: Response to ALK-TKIs in a metastatic lung cancer patient with morphological heterogeneity and consistent molecular features;Frontiers in Oncology;2023-08-11